Brief Summary
Type:
Lymphomas
Study Type:
Treatment
Phase:
III
ClinicalTrials.gov Identifier:
NCT03112174
Study #:
STUDY00141977
Start Date:
Jul 16, 2018
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT03112174
View Complete Trial Details & Eligibility at ClinicalTrials.gov
